|
||
|
||||||||||
Contents Page 1 |
What They Don't Tell You About XenicalXenical blocks about 1/3 of dietary fat from being digested. It is recommended for use three times daily with a mildly reduced calorie diet that contains no more than 30% of calories from fat. The most generous diet listed in the patient information from Hoffmann-La Roche contains 2000 calories and 67 grams of fat. Xenical would block about 22 grams of that fat. The amount of fat that you can eat while taking Xenical is limited -- if you eat too much fat you will get some very unpleasant diarrhea because the fat is eliminated from the bowel in its oily undigested form. I have not tried it, but I have seen a number of posts in newsgroups where Xenical was referred to as a form of aversion therapy. (In other words, the nasty side effects prevent or strongly discourage one from eating a high fat diet.) The patient information from Hoffmann-La Roche contains a good description of the side effects of Xenical:
|
|||||||||
Natrol Chitosan: 360 capsules (500 mg). Twinlab C-1000: 250 capsules (1000 mg).
"If there is no black and white, there can be
no gray -- since gray is merely a mixture of the two. Before one can identify anything as
"gray," one has to know what is black and what is white. In the field of
morality, this means that one must first identify what is good and what is evil. And when
a man has ascertained that one alternative is good and the other is evil, he has no
justification for choosing a mixture." -- Ayn Rand.
Written |
As we learned on page 1 of this post, Hoffmann-La Roche has a patent on chitosan because they know it can dramatically reduce the side effects of Xenical. However, they do not even mention chitosan in their patient information from Hoffmann-La Roche. Instead of telling us the truth about chitosan, they give us a bunch of crap about the side effects being a "natural effect" of Xenical that lets us know it's working. (Yeah right, and you got the chitosan patent so people wouldn't know Xenical was working, huh?) So "if you are concerned" about the nasty side effects of Xenical, but your "doctor or pharmacist" doesn't keep up with the latest patent filings, I guess you are just tough out of luck. Meanwhile, as we learned on page 1, Hoffmann-La Roche is busy funding bogus research designed to make chitosan look bad. Together these actions paint a scandalously ugly picture. But I have no doubt the mainstream media will use the Hoffmann-La Roche "research" to slam supplements instead of doing any real journalistic investigation. Depending on your point of view, our watchdogs are either pathetically lame or they have been bought and paid for. By the way, speaking of "watchdogs," the Xenical
Consumer Information from the FDA also does not bother to tell us that chitosan can
greatly reduce the side effects of Xenical. Given the FDA's bias against supplements this
is not too surprising. However, to be fair, I must admit that the FDA is improving -- they
have gone from outright lying about thermogenic supplements to merely lying by omission
about chitosan.
At any rate, 22 grams per day should serve as a pretty good estimate of the amount of fat blocked by Xenical. This costs about $110 a month ($3.66 a day). Of course, there is also the expense of obtaining a prescription, but for the sake of simplicity, I'm not going to try to figure that into the total cost. Suffice it to say, that is a LOT of money to block 22 grams of fat a day. Let's see how it compares to the chitosan/vitamin C combination. |
|||||||||
|
Home |
1.) Guerciolini R; Radu-Radulescu L; Boldrin M; Dallas J, and Moore R. "Comparative evaluation of fecal fat excretion induced by orlistat and chitosan." Obes Res, 2001 Jun; Vol: 9; Number: 6; Page: 364-7; PMID: 11399783. 2.) Pittler MH; Abbot NC; Harkness EF, and Ernst E. "Randomized, double-blind trial of chitosan for body weight reduction." Eur J Clin Nutr, 1999 May; Vol: 53; Number: 5; Page: 379-81; PMID: 0010369493. 3.) Wuolijoki E; Hirvela T, and Ylitalo P. "Decrease in serum LDL cholesterol with microcrystalline chitosan." Methods Find Exp Clin Pharmacol, 1999 Jun; Vol: 21; Number: 5; Page: 357-61; PMID: 0010420392. 4-NA.) Kanauchi O; Deuchi K; Imasato Y; and Kobayashi E. "Increasing effect of a chitosan and ascorbic acid mixture on fecal dietary fat excretion." Biosci Biotechnol Biochem, 1994; Vol: 58; Page: 1617-20. 5.) Kanauchi O; Deuchi K; Imasato Y; Shizukuishi M, and Kobayashi E. "Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate." Biosci Biotechnol Biochem, 1995 May; Vol: 59; Number: 5; Page: 786-90; PMID: 0007787293. 6.) Deuchi K; Kanauchi O; Imasato Y, and Kobayashi E. "Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet." Biosci Biotechnol Biochem, 1995 May; Vol: 59; Number: 5; Page: 781-5; PMID: 0007787292. 7-BK.) Fox, Arnold and Adderly, Brenda. "The Fat Blocker Diet." New York: St. Martin's Press; 1997; ISBN: 0-312-17102-1. 8.) Sugano M; Fujikawa T; Hiratsuji Y; Nakashima K; Fukuda N, and Hasegawa Y. "A novel use of chitosan as a hypocholesterolemic agent in rats." Am J Clin Nutr, 1980 Apr; Vol: 33; Number: 4; Page: 787-93; PMID: 0007361697. 9.) Razdan A; Pettersson D, and Pettersson J. "Broiler chicken body weights, feed intakes, plasma lipid and small- intestinal bile acid concentrations in response to feeding of chitosan and pectin." Br J Nutr, 1997 Aug; Vol: 78; Number: 2; Page: 283-91; PMID: 0009301417. 10.) Kondo H and Osada A. "Influence of dietary fiber on the bioavailability of zinc in rats." Biomed Environ Sci, 1996 Sep; Vol: 9; Number: 2-3; Page: 204-8; PMID: 0008886332. 11.) Deuchi K; Kanauchi O; Shizukuishi M, and Kobayashi E. "Continuous and massive intake of chitosan affects mineral and fat- soluble vitamin status in rats fed on a high-fat diet." Biosci Biotechnol Biochem, 1995 Jul; Vol: 59; Number: 7; Page: 1211-6; PMID: 0007670180. 12.) Wada M; Nishimura Y; Watanabe Y; Takita T, and Innami S. "Accelerating effect of chitosan intake on urinary calcium excretion by rats." Biosci Biotechnol Biochem, 1997 Jul; Vol: 61; Number: 7; Page: 1206-8; PMID: 0009255987. 13.) Razdan A and Pettersson D. "Hypolipidaemic, gastrointestinal and related responses of broiler chickens to chitosans of different viscosity." Br J Nutr, 1996 Sep; Vol: 76; Number: 3; Page: 387-97; PMID: 0008881711. 14.) Zacour AC; Silva ME; Cecon PR; Bambirra EA, and Vieira EC. "Effect of dietary chitin on cholesterol absorption and metabolism in rats." J Nutr Sci Vitaminol (Tokyo), 1992 Dec; Vol: 38; Number: 6; Page: 609-13; PMID: 0001304604. 15.) Hollander PA; Elbein SC; Hirsch IB; Kelley D; McGill J; Taylor T; Weiss SR; Crockett SE; Kaplan RA; Comstock J; Lucas CP; Lodewick PA; Canovatchel W; Chung J, and Hauptman J. "Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study." Diabetes Care, 1998 Aug; Vol: 21; Number: 8; Page: 1288-94; PMID: 0009702435. 16.) Melia AT; Koss-Twardy SG, and Zhi J. "The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers." J Clin Pharmacol, 1996 Jul; Vol: 36; Number: 7; Page: 647-53; PMID: 0008844448. 17.) Ormrod DJ; Holmes CC, and Miller TE. "Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis." Atherosclerosis, 1998 Jun; Vol: 138; Number: 2; Page: 329-34; PMID: 0009690916. 18.) Gallaher CM; Munion J; Hesslink R Jr; Wise J, and Gallaher DD. "Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats." J Nutr, 2000 Nov; Vol: 130; Number: 11; Page: 2753-9; PMID: 11053517. 19.) LeHoux JG and Grondin F. "Some effects of chitosan on liver function in the rat." Endocrinology, 1993 Mar; Vol: 132; Number: 3; Page: 1078-84; PMID: 0007679967. 20.) Kondo Y; Nakatani A; Hayashi K, and Ito M. "Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice." Biol Pharm Bull, 2000 Dec; Vol: 23; Number: 12; Page: 1458-64; PMID: 11145178. 21.) Miura T; Usami M; Tsuura Y; Ishida H, and Seino Y. "Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice." Biol Pharm Bull, 1995 Nov; Vol: 18; Number: 11; Page: 1623-5; PMID: 0008593495. 22.) Jennings CD; Boleyn K; Bridges SR; Wood PJ, and Anderson JW. "A comparison of the lipid-lowering and intestinal morphological effects of cholestyramine, chitosan, and oat gum in rats." Proc Soc Exp Biol Med, 1988 Oct; Vol: 189; Number: 1; Page: 13-20; PMID: 0003186761. |
||